The following are recent financial reports as posted by selected Utah corporations:
Green Dot
Green Dot Corp., based in Provo, reported net income of $5.1 million, or 9 cents per share, for the fourth quarter ended Dec. 31. That compares with a net loss of $23.6 million, or 45 cents per share, for the same quarter a year earlier.
Operating revenues in the most recent quarter totaled $455 million, up from $366 million in the year-earlier quarter.
For the full year 2024, the company reported a net loss of $26.7 million, or 50 cents per share. That compares with net income of $6.7 million, or 13 cents per share, for 2023. For the full year 2024, operating revenues totaled $1.72 billion, up from $1.5 billion in 2023.
Green Dot is a financial technology platform and registered bank holding company that builds banking and payment solutions.
“It was a solid year and fourth quarter for Green Dot as we accelerated revenue and earnings growth and saw our first positive quarter of account growth in several years,” George Gresham, CEO, said in announcing the results. “We balanced the impact of ongoing headwinds with operational improvements and growth in our B2B and embedded finance businesses, aided by new partner wins including Varo, Clip Money, DolFintech and others, reflecting the increasing demand and growth opportunity in embedded finance and Green Dot’s unique value proposition.
“This reinforces our investments in Arc, our embedded finance brand and platform, and further bolsters my confidence in our growth strategy and path forward.”
Myriad Genetics
Myriad Genetics Inc., based in Salt Lake City, reported a net loss of $42.5 million, or 47 cents per share, for the fourth quarter ended Dec. 31. That compares with a loss of $31.2 million, or 36 cents per share, for the same quarter a year earlier.
Revenue in the most recent quarter totaled $210.6 million, up from $196.6 million for the year-earlier quarter.
For the full year 2024, the company reported a net loss of $127.3 million, or $1.41 per share. That compares with a loss of $263.3 million, or $3.18 per share, for 2023. Revenue in 2024 totaled $837.6 million, up from $753.2 million in 2023.
Myriad Genetics is a molecular diagnostic testing and precision medicine company.
“There is a lot for Myriad Genetics to be proud of in 2024,” Paul J. Diaz, president and CEO, said in announcing the results. “We generated 11 percent revenue growth over 2023, making this our second consecutive year of double-digit growth, and $40 million in adjusted EBITDA (earnings before interest, taxes, depreciation and amortization). This achievement is the result of the company’s multi-year investment strategy along with our team’s hard work and focus on the needs of our patients and the health care providers who serve them.”
Purple
Purple Innovation Inc., based in Lehi, reported a net loss of $8.5 million, or 8 cents per share, for the fourth quarter ended Dec. 31. That compares with a loss of $18.3 million, or 17 cents per share, for the same quarter a year earlier.
Revenue in the most recent quarter totaled $129 million, down from $145.9 million in the year-earlier quarter.
For the full year 2024, the company reported a net loss of $97.9 million, or 91 cents per share. That compares with a loss of $120.8 million, or $1.17 per share, for 2023.
Net revenue in 2024 totaled $487.9 million, down from $510.5 million in 2023.
Purple manufactures mattresses, pillows, cushions, frames, sheets and other products.
“Purple achieved a significant milestone in the fourth quarter, returning to positive adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) for the first time in eight quarters and generating positive cash flow,” Rob DeMartini, CEO, said in announcing the results. “This accomplishment reflects our team's disciplined execution, operational improvements, and strategic cost-saving initiatives throughout the year.”
Nature’s Sunshine
Nature’s Sunshine Products Inc., based in Lehi, reported a net loss attributable to common shareholders of $321,000, or 2 cents per share, for the fourth quarter ended Dec. 31. That compares with net income of $9 million, or 46 cents per share, for the same quarter a year earlier.
Sales in the most recent quarter totaled $118.2 million, up from $108.9 million in the year-earlier quarter.
For the full year 2024, the company reported net income attributable to common shareholders of $7.7 million, or 40 cents per share. That compares with $15.1 million, or 77 per share, for 2023. Net sales in 2024 totaled $454.4 million, up from $445.3 million in 2023.
Nature’s Sunshine Products manufactures herbal and nutritional supplements.
“The fourth quarter was one of our strongest quarters ever, with revenue of $118 million, reflecting growth of 8.5 percent year-over-year and 10 percent on a constant currency basis,” Terrence Moorehead, CEO, said in announcing the results. “Our 21 percent growth in Asia Pacific and the continued execution of our strategies in Europe were key drivers of success. We are also encouraged by the 17 percent increase in North America digital sales, which demonstrates the continued strength of our digital platform.”
Clarus
Clarus Corp., based in Salt Lake City, reported a net loss of $65.5 million, or $1.71 per share, for the fourth quarter ended Dec. 31. That compares with a loss of $8.4 million, or 22 cents per share, for the same quarter a year earlier.
Sales in the most recent quarter totaled $71.4 million, down from $76.5 million in the year-earlier quarter.
For the full year 2024, the company reported a net loss of $52.3 million, or $1.37 per share. That compares with a loss of $10.1 million, or 27 cents per share, for 2023. Sales in 2024 totaled $264.3 million, down from $286 million in 2023.
Clarus designs and develops equipment and lifestyle products for outdoor enthusiasts.
“During 2024 we remained focused on executing against our strategic roadmap and positioning Clarus for profitable growth over the long term,” Warren Kanders, executive chairman, said in announcing the results. “Despite significant market headwinds, we took important steps during the year to simplify and strengthen the core at the Outdoor segment, while investing in new R&D and product development initiatives to scale the Adventure segment.”
Kanders said the company enters 2025 “encouraged by the strides our teams have made to advance our turnaround and excited about the potential to unlock new growth opportunities going forward. Following multiple quarters of incremental progress at Outdoor, we believe our success simplifying the business, rightsizing inventory and reshaping the organization positions Black Diamond for a return to growth as the market stabilizes.”
Domo
Domo Inc., based in American Fork, reported a net loss of $17.7 million, or 45 cents per share, for the fourth quarter ended Jan. 31. That compares with a loss of $18.7 million, or 51 cents per share, for the same quarter a year earlier.
Revenue in the most recent quarter totaled $78.8 million, down from $80.2 million in the year-earlier quarter.
For the most recent fiscal year, the company reported a net loss of $81.9 million, or $2.13 per share. That compares with a loss of $75.6 million, or $2.10 per share, for the prior fiscal year. Revenue in the most recent year totaled $317 million, down from $319 million.
Domo offers an AI and data products platform for companies.
“In FY25, we laid the foundation for durable, repeatable growth by focusing on ecosystem partners, the consumption model, and innovative AI solutions,” Josh James, founder and CEO, said in announcing the results.
“I’m proud our Domo team has made substantial progress while also delivering dramatic improvements in RPO, demonstrating the strength of our customer relationships. Domo was made for this rapidly evolving AI and data environment, and we are thrilled to be executing strategically, while also guiding to billings growth for this year and cash flow generation this quarter and this year.”
Owlet
Owlet Inc., based in Lehi, reported a net loss of $9.1 million, or 63 cents per share, for the fourth quarter ended Dec. 31. That compares with a loss of $6.9 million, or 97 cents per share, for the same quarter a year earlier.
Revenue in the most recent quarter totaled $20.5 million, down from $21 million in the year-earlier quarter.
For the full year 2024, the company reported a net loss of $12.5 million, or $1.57 per share. That compares with a loss of $32.9 million, or $4.53 per share, for 2023. Revenue in 2024 totaled $78.1 million, up from $54 million in 2023.
Owlet offers a digital health infant monitoring platform.
“2024 was a pivotal year for Owlet, marking our strongest financial performance in company history,” Kurt Workman, CEO and co-founder, said in announcing the results. “We finished the year strong with fourth-quarter results that exceeded our guidance across all key metrics. We made significant progress in the year, including launching the first and only FDA-cleared baby monitoring device, expanding internationally, and capturing market share, positioning Owlet as a clear leader in connected pediatric health.”